down arrow

Jubilant Pharmo

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
898.15
68.15 (8.21%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
6,702.90
6,281.73
6,130.16
6,098.54
5,975.79
9,110.82
7,464.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
93.06
Total Operating income
6,702.90
6,281.73
6,130.16
6,098.54
5,975.79
9,110.82
7,557.81
Raw Material Cost
1,821.30
1,666.41
1,348.70
1,348.75
1,438.02
3,282.80
2,678.15
Purchase of Finished goods
241.20
252.22
201.62
167.63
154.62
240.91
242.82
(Increase) / Decrease In Stocks
78.20
-40.70
-62.32
19.63
-137.46
-1.87
-52.20
Employee Cost
2,216.00
2,166.02
2,043.39
1,922.88
1,843.22
1,925.96
1,555.88
Power Cost
0.00
0.00
0.00
0.00
112.21
466.38
424.91
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
1,149.90
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,445.40
1,461.53
1,442.44
1,243.18
1,017.23
1,457.63
39.97
Total Expenditure (Excl Depreciation)
5,802.10
5,505.48
4,973.83
4,702.07
4,427.84
7,371.81
6,039.43
Operating Profit (PBDIT) excl Other Income
900.80
776.25
1,156.33
1,396.47
1,547.95
1,739.01
1,518.38
Other Income
68.70
38.33
11.29
17.64
37.41
35.74
40.03
Operating Profit (PBDIT)
969.50
814.58
1,167.62
1,414.11
1,585.36
1,774.75
1,558.41
Interest
272.30
188.20
145.49
184.10
199.71
219.81
284.28
Exceptional Items
-168.90
-56.82
0.00
-21.23
-32.94
-280.23
0.00
Gross Profit (PBDT)
528.30
569.56
1,022.13
1,208.78
1,352.71
1,274.71
1,274.13
Depreciation
381.90
554.03
381.70
348.95
339.84
370.90
415.05
Profit Before Tax
146.40
15.53
640.43
859.83
1,012.87
903.81
859.08
Tax
97.80
92.66
217.43
297.22
335.10
326.80
224.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.60
-77.13
423.00
562.61
677.77
577.01
634.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
261.75
220.47
0.00
0.00
Net Profit
48.60
-77.13
423.00
824.36
898.24
577.01
634.42
Share in Profit of Associates
24.10
12.25
-9.98
11.25
0.00
0.00
0.00
Minority Interest
4.40
3.90
0.92
0.26
0.00
-2.55
8.39
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
77.10
-60.98
413.94
835.87
898.24
574.46
642.81
Equity Capital
15.80
15.91
15.92
15.92
15.93
15.93
15.58
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,418.10
5,383.37
5,302.64
4,725.57
5,587.95
4,792.99
4,070.95
Earnings per share (EPS)
4.88
-3.83
26.0
52.5
48.93
36.06
41.26
Diluted Earnings per share
4.86
-3.83
26.0
52.48
56.39
36.86
41.25
Operating Profit Margin (Excl OI)
13.56%
12.48%
19.08%
23.42%
26.49%
19.33%
20.09%
Gross Profit Margin
7.95%
9.16%
16.87%
20.27%
23.15%
14.17%
16.86%
PAT Margin
1.09%
-1.04%
6.82%
9.62%
11.6%
6.41%
8.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 6.70% vs 2.47% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 226.43% vs -114.73% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 16.05% vs -32.87% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 44.69% vs 29.36% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Jubilant Pharmo With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
6,702.90
10,334.77
-3,631.87
-35.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,702.90
10,334.77
-3,631.87
-35.14%
Raw Material Cost
1,821.30
1,853.52
-32.22
-1.74%
Purchase of Finished goods
241.20
1,409.85
-1,168.65
-82.89%
(Increase) / Decrease In Stocks
78.20
-53.67
131.87
245.71%
Employee Cost
2,216.00
2,274.73
-58.73
-2.58%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,445.40
2,315.28
-869.88
-37.57%
Total Expenditure (Excl Depreciation)
5,802.10
7,799.71
-1,997.61
-25.61%
Operating Profit (PBDIT) excl Other Income
900.80
2,535.06
-1,634.26
-64.47%
Other Income
68.70
280.86
-212.16
-75.54%
Operating Profit (PBDIT)
969.50
2,815.92
-1,846.42
-65.57%
Interest
272.30
33.53
238.77
712.11%
Exceptional Items
-168.90
0.00
-168.90
Gross Profit (PBDT)
528.30
2,782.39
-2,254.09
-81.01%
Depreciation
381.90
398.25
-16.35
-4.11%
Profit Before Tax
146.40
2,384.14
-2,237.74
-93.86%
Tax
97.80
457.58
-359.78
-78.63%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
48.60
1,926.56
-1,877.96
-97.48%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
48.60
1,926.56
-1,877.96
-97.48%
Share in Profit of Associates
24.10
15.21
8.89
58.45%
Minority Interest
4.40
-28.87
33.27
115.24%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
77.10
1,912.90
-1,835.80
-95.97%
Equity Capital
15.80
40.06
-24.26
-60.56%
Face Value
1.00
1.00
0.00
Reserves
5,418.10
9,323.03
-3,904.93
-41.88%
Earnings per share (EPS)
4.88
47.75
-42.87
-89.78%
Diluted Earnings per share
4.86
47.68
-42.82
-89.81%
Operating Profit Margin (Excl OI)
13.56%
24.53%
0.00
-10.97%
Gross Profit Margin
7.95%
26.92%
0.00
-18.97%
PAT Margin
1.09%
18.79%
0.00
-17.70%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 6,702.90 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 6.70% vs 2.47% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 77.10 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 226.43% vs -114.73% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 900.80 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 16.05% vs -32.87% in Mar 2023

Annual - Interest
Interest 272.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.69% vs 29.36% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.56%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023